Trials / Completed
CompletedNCT01410747
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Specified Drug Use-Results Survey on Long-Term Treatment for Prograf® Capsules 0.5 mg, 1 mg Lupus Nephritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,484 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use.
Detailed description
The objectives of the survey are to evaluate the safety and efficacy of tacrolimus for lupus nephritis under actual-use situations, and to identify factors that might affect the safety and efficacy of tacrolimus. In addition, long-term renal outcome will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | oral |
Timeline
- Start date
- 2007-04-10
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2011-08-05
- Last updated
- 2024-10-22
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01410747. Inclusion in this directory is not an endorsement.